v3.26.1
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses (recovery)        
General and administrative (recovery) $ (2,032) $ 4,500 $ 2,385 $ 10,266
Research and development (recovery) (4,705) 9,959 4,144 30,298
Total operating expenses (recovery) (6,737) 14,459 6,529 40,564
Operating income (loss) 6,737 (14,459) (6,529) (40,564)
Other income (expense)        
Grant income 25 37
Research and development incentive income 34 127 94 635
Interest income, net 1,072 1,075 3,212 3,679
Foreign exchange gain (loss) (19) (11) 46 (337)
Total other income, net 1,087 1,216 3,352 4,014
Net income (loss) before provision for income 7,824 (13,243) (3,177) (36,550)
Income tax expense, current (18)
Net income (loss) and comprehensive income (loss) $ 7,824 $ (13,243) $ (3,195) $ (36,550)
Net income (loss) per share        
Net Loss per share, Basic $ 0.08 $ (0.16) $ (0.03) $ (0.43)
Net Loss per share, Diluted $ 0.08 $ (0.16) $ (0.03) $ (0.43)
Weighted average number of shares outstanding        
Basic 92,696,842 85,380,587 91,453,995 85,085,795
Diluted 92,899,536 85,380,587 91,453,995 85,085,795